The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


The Annals of Pharmacotherapy: Vol. 31, No. 6, pp. 736-737.
© 1997 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maxa, J.
Right arrow Articles by Tanzi, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxa, J.
Right arrow Articles by Tanzi, M


Research Articles

Possible toxic encephalopathy following high-dose intravenous haloperidol

JL Maxa, AM Taleghani, CC Ogu, and M Tanzi

OBJECTIVE: To describe a case of possible toxic encephalopathy in a surgical patient receiving high-dose intravenous haloperidol. CASE SUMMARY: A 54-year-old African-American man was admitted for spinal fusion. His medical history included bipolar disorder and a cerebrovascular accident. His recovery from surgery was complicated by the development of agitation, which was treated with increasing doses of intravenous haloperidol. An electroencephalogram was consistent with toxic encephalopathy. The patient's mental status returned to normal 8 days after discontinuation of haloperidol. DISCUSSION: High-dose intravenous haloperidol for severe agitation has been reported as an effective and safe treatment option for the hospitalized patient. We report the occurrence of toxic encephalopathy in a patient who received high-dose intravenous haloperidol. CONCLUSIONS: Caution should be used when high-dose intravenous haloperidol is used in an agitated patient. If the patient's clinical response is paradoxical to what is anticipated and the resulting agitation is mistakenly attributed to inadequate treatment, increasingly higher doses may only aid in the development of toxic encephalopathy.





homecopy help contact us subscription past issues search current issue
Copyright © 1997 by Harvey Whitney Books Company.